Newsroom

Live webcast of the Shareholders’ Meeting on Tuesday, December 15, 2020

December 11, 2020

December 11, 2020

MedinCell publishes its first-half 2020/2021 financial results (April – September 2020): operating expenses and portfolio development in line with expectations

December 9, 2020

December 9, 2020

Videoconference • Half year results

December 9, 2020

MedinCell publishes its financial results and activity report for the first half of 2021-2022

December 8, 2020

December 8, 2020

Videoconference and publication of the 2020-2021 Half-Year Results, on December 9, 2020

December 2, 2020

December 2, 2020

First long-acting injectable (LAI) antipsychotic using MedinCell’s technology reaches Phase 3 clinical study primary completion date

November 12, 2020

November 12, 2020

Convening of the General Assembly: Proposal for the appointment of Elisabeth Kogan to the Supervisory Board

November 9, 2020

November 9, 2020

MedinCell initiates the first clinical trial of its Covid-19 prevention program

September 29, 2020

September 29, 2020

Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation

September 20, 2020

September 20, 2020

MedinCell releases the results of its September 10, 2020 ordinary annual and extraordinary general meeting

September 11, 2020

September 11, 2020

Participation terms in the MedinCell Combined General Meeting and availability of preparatory documents

July 31, 2020

July 31, 2020

MedinCell announces the availability of its 2019/2020 Universal Registration Document including the Annual Financial Report

July 29, 2020

July 29, 2020